Bibliografías temáticas / Chronic Obdstructive Pulmonary Disease

Índice

  1. Artículos de revistas
  2. Tesis
  3. Libros
  4. Capítulos de libros
  5. Actas de conferencias
  6. Informes

Literatura académica sobre el tema "Chronic Obdstructive Pulmonary Disease"

Autor: Grafiati
Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Chronic Obdstructive Pulmonary Disease".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

Russell, Richard y Jayne Norcliffe. "Chronic obstructive pulmonary disease: management of chronic disease". Medicine 36, n.º 4 (abril de 2008): 218–22. http://dx.doi.org/10.1016/j.mpmed.2008.01.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Russell, Richard, Jayne Norcliffe y Mona Bafadhel. "Chronic obstructive pulmonary disease: management of chronic disease". Medicine 40, n.º 5 (mayo de 2012): 262–66. http://dx.doi.org/10.1016/j.mpmed.2012.02.009.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Hambleton, Kirsty, Mona Bafadhel y Richard Russell. "Chronic obstructive pulmonary disease: management of chronic disease". Medicine 44, n.º 5 (mayo de 2016): 310–13. http://dx.doi.org/10.1016/j.mpmed.2016.02.019.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Ramakrishnan, Sanjay, Mona Bafadhel y Richard Russell. "Chronic obstructive pulmonary disease: management of chronic disease". Medicine 48, n.º 5 (mayo de 2020): 333–36. http://dx.doi.org/10.1016/j.mpmed.2020.02.002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Schneider, Sandra M. "Chronic Obstructive Pulmonary Disease". Emergency Medicine Clinics of North America 7, n.º 2 (mayo de 1989): 237–54. http://dx.doi.org/10.1016/s0733-8627(20)30335-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

MacIntyre, Neil R. "Chronic Obstructive Pulmonary Disease". Pharmacotherapy 24, n.º 5 Part 2 (mayo de 2004): 33S—43S. http://dx.doi.org/10.1592/phco.24.7.33s.34756.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Penz, Erika, Michael K. Stickland y Brandie Walker. "Chronic obstructive pulmonary disease". Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5, n.º 2 (4 de marzo de 2021): 84–88. http://dx.doi.org/10.1080/24745332.2021.1901630.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Kotolová, Hana y Tomáš Hammer. "Chronic obstructive pulmonary disease". Praktické lékárenství 14, n.º 4 (15 de diciembre de 2018): 156–60. http://dx.doi.org/10.36290/lek.2018.030.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Laine, Christine. "Chronic Obstructive Pulmonary Disease". Annals of Internal Medicine 148, n.º 5 (4 de marzo de 2008): ITC3. http://dx.doi.org/10.7326/0003-4819-148-5-200803040-01003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Fehrenbach, Chris. "Chronic obstructive pulmonary disease". Nursing Standard 17, n.º 10 (20 de noviembre de 2002): 45–51. http://dx.doi.org/10.7748/ns2002.11.17.10.45.c3302.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

McAllister, David Anthony. "Chronic obstructive pulmonary disease, pulmonary function and cardiovascular disease". Thesis, University of Edinburgh, 2011. http://hdl.handle.net/1842/5615.

Texto completo
Resumen
Cardiovascular disease is common in Chronic Obstructive Pulmonary Disease (COPD), and forced expiratory volume in one second (FEV1) independently predicts cardiovascular morbidity and mortality. Pathological changes in the systemic vasculature have been proposed as potential mechanisms linking COPD to cardiovascular disease, and patients with COPD may be at increased risk of acute myocardial infarction during acute exacerbations. Notwithstanding causation, FEV1 may be a useful prognostic marker in patients undergoing cardiac surgery. This thesis examined these three aspects of cardiovascular co-morbidity in relation to COPD and FEV1. In 2,241 consecutive cardiac surgery patients, FEV1 was associated with length of hospital stay (p<0.001) and mortality (p<0.001) adjusting for age, sex, height, body mass index, socioeconomic status, smoking, cardiovascular risk factors, chronic pulmonary disease, and type/urgency of surgery. In a survey of Scottish Respiratory Consultants there was no consensus regarding the investigation and management of acute coronary syndrome in exacerbation of COPD. In a case-series of 242 patients with exacerbations 2.5% (95% CI 1.0 to 5.6%) had chest pain, raised serum troponin and serial electrocardiogram changes suggestive of acute coronary syndrome. However, over half reported chest pain, while raised troponin was not associated with chest pain or serial ECG changes. Carotid-radial pulse wave velocity (PWV), aortic distensibility, and aortic calcification were measured to assess the relationship of the systemic vasculature to FEV1 and emphysema severity on CT. In adjusted analyses, emphysema was associated with PWV in patients with COPD (p = 0.006) and, in population based samples, with extent of distal aortic calcification (p=0.02) but not with aortic distensibility (p=0.60). This thesis found that FEV1 was associated with mortality and length of hospital stay in patients undergoing cardiac surgery, and that chest pain and raised troponin were common but unrelated in exacerbation of COPD. In the vascular studies distal but not proximal vascular pathology was associated with FEV1, and if COPD is truly related to systemic arterial disease, the distal arterial tree is implicated.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Murphy, Nicola. "Chronic obstructive pulmonary disease and anxiety". Thesis, Coventry University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368862.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Solomon, Brahm Kevin. "Psychological Aspects of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease". Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/34292.

Texto completo
Resumen
As a leading cause of disability that often leads to death, chronic obstructive pulmonary disease (COPD) can be characterized as both a chronic illness and a life-threatening one. As a result, the experience of individuals with COPD can include psychological concerns that are associated with both rehabilitation and palliative care. At the same time, the often-uncertain trajectory of COPD obscures a clear transition from rehabilitation to palliative care. It is not surprising, therefore, that treatments aimed at addressing patients’ rehabilitative and palliative needs largely proceed independently of each other. This dissertation contains two studies conducted with patients participating in a pulmonary rehabilitation program for COPD (N = 242). Separately, each study stems from a research tradition grounded in either the rehabilitative or palliative approach to treatment. Together, the studies highlight an opportunity for a model of more integrated care. Study 1 is derived from the rehabilitation literature and focuses on the issue of “catastrophizing” about breathlessness. Catastrophizing is characterized by a magnification of a symptom’s threat value, rumination about its perceived negative impact, and a sense of helplessness in addressing it. In some medical conditions with a primary symptom, such as chronic pain, catastrophizing demonstrates a strong relationship with the development of disability. Study 1 examines whether this relationship is found in the context of breathlessness. The study also reports the initial validation of the Breathlessness Catastrophizing Scale (BCS) as a means of assessing this phenomenon. Study 2 has its conceptual basis in the palliative care literature and highlights patients’ existential concerns around loss of dignity. Loss of dignity is a central construct in recent health care debates, because it is a primary reason underlying the requests of terminally ill individuals to seek medically hastened deaths (i.e., euthanasia or assisted suicide). Until now, however, loss of dignity has only been examined among patients with cancer. Study 2 examines whether loss of dignity is as prevalent among those with advanced COPD, and whether it improves with treatment. In Study 1 the BCS was found to be a reliable measure of breathlessness catastrophizing, with good convergent validity and sensitivity to change. Interestingly, it appears that breathlessness catastrophizing need not be a barrier to functional improvement in COPD. In Study 2, a “fractured” sense of dignity was found among 13% of patients with advanced COPD, suggesting that it is at least as prevalent as among those receiving palliative cancer care. It was also evident that loss of dignity is amenable to change with appropriate rehabilitation. This finding is important for societal debates regarding the provision of medically hastened deaths, which are often described as offering “death with dignity”. Together these studies demonstrate that in an interdisciplinary environment, such as the pulmonary rehabilitation program, not only is collaboration possible, but the distinct rehabilitative and palliative needs of patients can be met.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Greening, Neil James. "Early pulmonary rehabilitation for exacerbations of chronic obstructive pulmonary disease". Thesis, University of Leicester, 2014. http://hdl.handle.net/2381/29155.

Texto completo
Resumen
Exacerbations are key events in the natural history of chronic obstructive pulmonary disease (COPD), with limited recovery of physical performance, and the highest cause of readmission in the UK. This thesis explores the impact of exacerbations in COPD and chronic respiratory disease. In the first study I have investigated the effects of an early rehabilitation intervention on healthcare utilisation, strength and exercise capacity by conducting a large randomised control trial. Using a sub-group of this cohort I have then explored factors that predict hospital readmission. Finally I have conducted a study of single leg neuromuscular electrical stimulation (NMES) in stable COPD, alongside a resistance training group. No difference was seen following early rehabilitation in hospitalisation, healthcare utilisation or physical performance. A number of unexpected findings were noted, including an increase in 12 month mortality in the intervention group and large functional recovery in the usual care group. Using multivariate analysis three risk factors for hospital readmission were identified, including quadriceps cross sectional area, using ultrasound. In the stable state NMES was seen to significantly increase muscle mass from baseline, comparable to changes seen using resistance training. In summary early rehabilitation in chronic respiratory disease does not impact on future hospitalisation. Identification of those with rehabilitation potential is required as the hospitalised population represent a frail group, with advanced disease.
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

John, Michelle. "The extra-pulmonary effects of chronic obstructive pulmonary disease (COPD)". Thesis, University of Nottingham, 2014. http://eprints.nottingham.ac.uk/14405/.

Texto completo
Resumen
Rationale Cardiovascular disease (CVD) is a leading cause of mortality in patients with COPD. Aortic stiffness, measured using aortic pulse wave velocity (PWV), an independent, non-invasive, predictor of CV risk; and inflammatory markers are increased in COPD. Screening tools for community based identification of increased CVD risk, and a proactive approach to addressing primary prevention of CVD is needed. Statins modulate aortic stiffness and are anti-inflammatory, but are not currently used for primary prevention in COPD. Objectives Proof of principle double-blind Randomised Control Trial (RCT) to determine if six weeks simvastatin 20mg od reduces aortic stiffness, systemic and airway inflammation in COPD. Cross-sectional pilot study comparing a non-invasive measure of oxidative stress (skin “AGE”) in COPD and controls, to lung function and aortic stiffness. Methods Stable patients (n=70) were randomised to simvastatin or placebo treatment. Pre- and post-treatment aortic stiffness, blood pressure, spirometry, circulating inflammatory mediators and lipids were measured; airway inflammatory markers were performed where possible. Predefined subgroup analysis was performed where baseline aortic PWV >10m/s. For the cross-sectional study stable COPD patients (n=84) and controls (n=36) had lung function, arterial stiffness and skin AGE measured. Results In the RCT the active group achieved significantly lower total cholesterol, but no significant drop in aortic PWV compared to placebo group: -0.7(95%CI -1.8,0.5)m/s, p=0.24; or inflammatory markers. In those with higher baseline aortic PWV, n=22, aortic PWV improved in the active group compared to placebo: -2.8(-5.2,-0.3)m/s, p=0.03. Skin AGE was increased in COPD compared to controls, inversely related to lung function, and directly related to aortic stiffness. Conclusions We could not detect any significant difference in the change in aortic PWV in patients with COPD taking simvastatin compared to placebo. We did, however, report a significant and clinically relevant reduction in aortic PWV in those with high baseline aortic stiffness, suggesting a potential for statins to reduce CV morbidity in high risk individuals. The pilot cross-sectional study suggests there is an indication to assess the potential role of skin AGE in patients with COPD as a non-invasive measure of CV risk.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Roos-Engstrand, Ester. "T cells in chronic obstructive pulmonary disease". Doctoral thesis, Umeå : Umeå university, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-33677.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Stevenson, Nicola Jane. "Lung mechanics in chronic obstructive pulmonary disease". Thesis, University of Liverpool, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.432977.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Wodehouse, Theresa. "Ciliary aspects of chronic sino-pulmonary disease". Thesis, Imperial College London, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271952.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Al-shair, Khaled. "Systemic Manifestations of Chronic Obstructive Pulmonary Disease". Thesis, University of Manchester, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509061.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Revill, Susan M. "Endurance exercise in chronic obstructive pulmonary disease". Thesis, Loughborough University, 1997. https://dspace.lboro.ac.uk/2134/15388.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

Nakamura, Hiroyuki y Kazutetsu Aoshiba, eds. Chronic Obstructive Pulmonary Disease. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-0839-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Nici, Linda y Richard ZuWallack, eds. Chronic Obstructive Pulmonary Disease. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-60761-673-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Stockley, Robert A., Stephen I. Rennard, Klaus Rabe y Bartolome Celli, eds. Chronic Obstructive Pulmonary Disease. Oxford, UK: Blackwell Publishing Ltd, 2007. http://dx.doi.org/10.1002/9780470755976.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Calverley, P. M. A. y N. B. Pride, eds. Chronic Obstructive Pulmonary Disease. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-4525-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

National Heart, Lung, and Blood Institute., ed. Chronic obstructive pulmonary disease. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

1939-, Hodgkin John E., ed. Chronic obstructive pulmonary disease. Philadelphia: W. B. Saunders, 1990.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Currie, Graeme P. Chronic obstructive pulmonary disease. Oxford: Oxford University Press, 2009.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

1932-, Petty Thomas L., ed. Chronic obstructive pulmonary disease. 2a ed. New York: Dekker, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Rochester, Carolyn L. Chronic obstructive pulmonary disease. Philadelphia: W.B. Saunders Co., 2000.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Celli, Bartolome R. y Stephen I. Rennard. Chronic obstructive pulmonary disease. Philadelphia, Pennsylvania: Saunders, an imprint of Elsevier, Inc., 2012.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

Farver, Carol, Subha Ghosh, Thomas Gildea y Charles D. Sturgis. "Chronic Obstructive Pulmonary Diseases". En Pulmonary Disease, 145–60. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47598-7_11.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Clark, C. J. "Pulmonary Rehabilitation". En Chronic Obstructive Pulmonary Disease, 527–45. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-4525-9_21.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Troosters, Thierry. "Cardiovascular Disease". En Chronic Obstructive Pulmonary Disease, 47–59. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-673-3_4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Pratt, Philip C. "Emphysema and Chronic Airways Disease". En Pulmonary Pathology, 651–69. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4757-3932-9_24.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Pratt, Philip C. "Emphysema and Chronic Airways Disease". En Pulmonary Pathology, 847–65. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-3935-0_26.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Underwood, David C. "Chronic obstructive pulmonary disease". En In Vivo Models of Inflammation, 159–77. Basel: Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Bertholet, Renette y Inessa McIntyre. "Chronic Obstructive Pulmonary Disease". En Patient Assessment in Clinical Pharmacy, 213–24. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_16.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Stucky, Kirk y Jeff Greenblatt. "Chronic Obstructive Pulmonary Disease". En Comprehensive Handbook of Clinical Health Psychology, 277–300. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118269657.ch12.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Kozora, Elizabeth y Karin F. Hoth. "Chronic Obstructive Pulmonary Disease". En Encyclopedia of Clinical Neuropsychology, 782–85. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_545.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Franco, S. y Marilyn Glassberg. "Chronic Obstructive Pulmonary Disease". En Encyclopedia of Women’s Health, 262–64. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_88.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

Balasubramanian, A., T. M. Kolb, R. L. Damico, P. M. Hassoun, M. C. McCormack y S. C. Mathai. "Characterization of Chronic Obstructive Pulmonary Disease-Pulmonary Hypertension". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5961.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Calancea, Valentin, Eudochia Terna, Tatiana Dumitras, Doina Barba, Irina Cosciug y Sergiu Matcovschi. "Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease". En ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2464.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Jakimova, Marina Artemovna, Natalya Karpina, Olga Gordeeva y Rasul Asanov. "Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease". En ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2969.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Sokolovic, Irena, Jelena Knezevic, Sanja Popovic-Grle, Andrea Vukic Dugac, Gordana Bubanovic, Mateja Jankovic Makek, Ana Hecimovic, Gzim Redzepi, Miroslav Samarzija y Marko Jakopovic. "Chronic obstructive pulmonary disease and comorbidities". En Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1123.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Nadia, Fettal, Beziou Yamina y Taleb Abdessamed. "Diabetes and chronic obstructive pulmonary disease". En ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4319.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Walid, Feki, Chaabouni Malek, Ketata Wajdi, Moussa Nadia, Bahloul Najla, Msaad Sameh, Kotti Amina et al. "Chronic pain in patients with chronic obstructive pulmonary disease". En ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Mirdamadi, Mahsa, Hosnollah Sadeghi, Ali Safaei y Mahmood Salesi. "Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients". En ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4061.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Gupta, V., D. Singh, S. Pandit, P. Bhadoria y D. P. Bhadoria. "Prevalence of Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome in Indian Patients of Chronic Obstructive Pulmonary Disease". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4746.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Gill, K. y D. Lee. "More than Just Chronic Obstructive Pulmonary Disease". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6449.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

DeMeo, DL, CP Hersh, B. Klanderman, AA Litonjua y EK Silverman. "Aging Genes and Chronic Obstructive Pulmonary Disease." En American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3000.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Chronic Obdstructive Pulmonary Disease"

1

Lin, Chun-Long. Prevalence and prognosis of pulmonary hypertension in patients with chronic kidney disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, febrero de 2023. http://dx.doi.org/10.37766/inplasy2023.2.0051.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Wang, Yanping, Mingru Huang, Liping Tang, Lingxia Xu, Jiangfeng Wu, Fei Wang y Ying Zhang. Moxibustion for stable chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2021. http://dx.doi.org/10.37766/inplasy2021.4.0047.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Czerwaty, Katarzyna, Karolina Dżaman, Krystyna Maria Sobczyk y Katarzyna Irmina Sikrorska. The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, noviembre de 2022. http://dx.doi.org/10.37766/inplasy2022.11.0077.

Texto completo
Resumen
Review question / Objective: To provide the essential findings in the field of overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea, including prevalence, possible predictors, association with clinical outcomes, and severity compared to both chronic obstructive pulmonary disease and obstructive sleep apnea patients. Condition being studied: OSA is characterized by complete cessation (apnea) or significant decrease (hy-popnea) in airflow during sleep and recurrent episodes of upper airway collapse cause it during sleep leading to nocturnal oxyhemoglobin desaturations and arousals from rest. The recurrent arousals which occur in OSA lead to neurocognitive consequences, daytime sleepiness, and reduced quality of life. Because of apneas and hypopneas, patients are experiencing hypoxemia and hypercapnia, which result in increasing levels of catecholamine, oxidative stress, and low-grade inflammation that lead to the appearance of cardio-metabolic consequences of OSA. COPD is a chronic inflammatory lung disease defined by persistent, usually pro-gressive AFL (airflow limitation). Changes in lung mechanics lead to the main clini-cal manifestations of dyspnea, cough, and chronic expectoration. Furthermore, patients with COPD often suffer from anxiety and depression also, the risk of OSA and insomnia is higher than those hospitalized for other reasons. Although COPD is twice as rare as asthma but is the cause of death eight times more often.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Feng, Zhenzhen, Xuanlin Li, Yang Xie y Jiansheng Li. Effectiveness of Tai Chi for Chronic obstructive Pulmonary Disease: Overview of Systematic Reviews and Meta-analyses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, octubre de 2020. http://dx.doi.org/10.37766/inplasy2020.10.0114.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Zhou, Wen. Does benralizumab effectively treat chronic obstructive pulmonary disease? a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, abril de 2020. http://dx.doi.org/10.37766/inplasy2020.4.0039.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Xue, Jiali, Xiaona Zhang, Hongyan Lu, Xirui Jiang, Fang Yu y Pengfei Yang. Nonpharmacological interventions for chronic obstructive pulmonary disease-related fatigue: A systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, septiembre de 2022. http://dx.doi.org/10.37766/inplasy2022.9.0072.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco y Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Texto completo
Resumen
Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statistical Classification of Diseases and Related Health Problems (ICD) from OMS) and international guidelines of each disease.
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Lei, Yuping, Meili Wang, Guiqiang Sun, Yong Liu, Yapei Yang y Dong Hao. Chinese herbal medicine injections (CHMIs) for chronic pulmonary heart disease: protocol for a Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, diciembre de 2020. http://dx.doi.org/10.37766/inplasy2020.12.0004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Li, Shuyao, Wenshuang Zhang y Tong Guan. Effect of Bifidobacterium Bifidum for Chronic Obstructive Pulmonary Disease in China: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junio de 2022. http://dx.doi.org/10.37766/inplasy2022.6.0023.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Xie, Rongfang, Chunyan Huang, Miaomiao Li y Zhihui Lan. Yiqi Wenyang Huoxue Method in Treating Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, agosto de 2022. http://dx.doi.org/10.37766/inplasy2022.8.0011.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Chronic Obdstructive Pulmonary Disease" para tipos de fuentes particulares:
Artículos de revistas Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía